title: Nucleos(t)ide analogs reduce the risk of hepatitis B-associated hepatocellular carcinoma: A can't miss proposition?
authors.affiliation: Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, CA.
authors.forename: Neil
authors.initials: N
authors.lastname: Mehta
authors.affiliation: Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, CA.
authors.forename: Francis Y
authors.initials: FY
authors.lastname: Yao
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D006509:Hepatitis B / Q000188:drug therapy*; D019694:Hepatitis B, Chronic / Q000188:drug therapy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy
chemical_list: D000998:Antiviral Agents